A potential new weapon in the addiction battle: FDA-approved diabetes and obesity drugs

(University of Pennsylvania) Research from the University of Pennsylvania reveals that FDA-approved drugs to treat diabetes and obesity may reduce cocaine relapse and help people who are addicted break the habit. Such medications work by targeting receptors for glucagon-like peptide 1, a hormone in the brain.